Lobster unveils its "Data World" - a digital ecosystem powering next-generation data integration
"As we navigate unpredictable landscapes, data has become one of the most powerful assets organisations have to mitigate risks and gain a competitive edge," said Tim Srock, CEO of Lobster. "The Data World isn't just another product – it's our vision for a truly connected world. We're empowering companies to eliminate recurring connectivity issues, anticipate challenges before they arise, and build smarter, more resilient supply chains."
Data World: Solving real-world data challenges
The Data World directly addresses today's most critical data integration pain points:
Breaking down data silos: Integrates legacy infrastructure with modern cloud platforms to unlock trapped data.
Seamless collaboration: Facilitates secure, real-time information exchange between trading partners through the Data Network.
Intelligent insights: AI-driven analytics uncover actionable patterns for smarter decision-making.
Accelerated innovation: Empowers teams to rapidly develop data-driven applications.
Simplified governance: Ensures secure data access and policy implementation through built-in compliance features.
The four pillars of the Data World
Data Network: Connects shippers, retailers, logistics service providers, carriers, tech vendors in a seamless, zero-touch ecosystem. Hundreds of network participants are already seeing the benefits of automated onboarding, enhanced visibility, and significant cost savings.
Data Ecosystem: The Data Ecosystem sustains our Data Network by bringing together strategic partners, a collaborative community, a dynamic marketplace, and continuous learning through Lobster Academy. This integrated approach accelerates innovation, empowers users, and drives value creation for customers.
Data Products: Out-of-the-box, plug-and-play solutions for critical business processes. With a few clicks, companies can leverage fully managed Data Poducts for purchasing, logistics operations, e-commerce, and even e-invoicing.
Data Platform: A configurable environment with intuitive drag-and-drop interfaces, enabling users – from developers to business teams – to create custom integrations and applications and even build on the functionality of the Data Products.
"Technology is an enabler; people drive transformation," said Jethro Borsje, Chief Product Officer at Lobster. "That's why Lobster Data World is designed to be intuitive, scalable, and accessible – putting the power in the hands of every user."
"The Lobster Data World is more than an evolution — it's a paradigm shift in connectivity," added Gonçalo Gaiolas, Chief Product & Technology Officer at SoSafe and Board Member of Lobster. "By unifying people, systems, and processes, Lobster is paving the way for a more adaptive and responsive global supply chain ecosystem."
Lobster introduced the Data World to over 1,000 attendees at its Data Hero Summit, held on May 14th in Munich, Germany. The event served as a platform for showcasing real-world use cases, partner integrations, and hands-on demos of the new offering in action.
About LobsterLobster is a software development company dedicated to connecting people and data for a better future. The Lobster Data World is a global data ecosystem that provides a 360° data view and empowers teams to solve challenges effectively. It eliminates complexity by enabling real-time integration and intelligent automation to break down silos and foster secure collaboration across complex supply chains.
With a presence in DACH, the UK, France, Scandinavia, and the Benelux – serving over 2,000 customers globally – Lobster enables companies to unlock the full potential of their data and stay agile in a rapidly evolving digital world.
Logo - https://mma.prnewswire.com/media/2687257/Lobster_Logo.jpgPhoto - https://mma.prnewswire.com/media/2687258/Data_World.jpg
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/lobster-unveils-its-data-world--a-digital-ecosystem-powering-next-generation-data-integration-302455331.html
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
26 minutes ago
- Yahoo
Former Nokia CEO joining Finnish quantum company's board
STOCKHOLM (Reuters) -Former Nokia CEO Pekka Lundmark will join Finnish quantum computing company QMill as an investor and a board member, the company said on Wednesday. Lundmark stepped down from the top job at Nokia earlier this year after being appointed as CEO in 2020, and is credited with turning around the telecom gear maker. Antti Vasara, former head of VTT Technical Research Centre of Finland, and a former Nokia executive, will also join QMill as chair of the board. Espoo, Finland-based QMill, is a quantum-algorithm company, which started operations last year, and has raised seed funding from Antler, and Kvanted. Quantum computing is emerging as a promising sector where many startups are working alongside tech companies such as Microsoft and Nvidia to build functional computers to solve problems that would take classical computers thousands of years. Fehler beim Abrufen der Daten Melden Sie sich an, um Ihr Portfolio aufzurufen. Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten
Yahoo
26 minutes ago
- Yahoo
Airbus workers to stage strikes amid pay dispute
Workers at aircraft manufacturer Airbus are to stage a series of strikes in a dispute over pay. Unite said around 3,000 of its members will walk out for 10 days in September after they voted overwhelmingly in favour of industrial action. Unite general secretary Sharon Graham said: 'Airbus is generating billions in profit; workers deserve a fair deal. Our members are simply seeking fairness not favours. 'Airbus workers have the total support of their union in this dispute.' Unite warned the strikes will hit production of wings for Airbus's commercial and military aircraft programmes.
Yahoo
26 minutes ago
- Yahoo
Coloplast AS (CLPBF) Q3 2025 Earnings Call Highlights: Strong Organic Growth Amidst Challenges
This article first appeared on GuruFocus. Organic Revenue Growth: 7% for the third quarter. EBIT Margin Before Special Items: 28% in the third quarter. Adjusted Return on Invested Capital: 15%, on par with last year. Ostomy Care Organic Growth: 6% for the first nine months. Continence Care Organic Growth: 8% for the first nine months. Voice and Respiratory Care Organic Growth: 9% for the first nine months. Advanced Wound Care Organic Growth: 9% for the first nine months. Kerecis Growth: 26% for the first nine months. Interventional Urology Organic Growth: 1% for the first nine months. Gross Margin: 68% for the first nine months. Operating Profit Before Special Items: DKK 5.7 billion for the first nine months. Net Profit Before Special Items: DKK 3.8 billion for the first nine months. Operating Cash Flow: DKK 4.4 billion for the first nine months. Free Cash Flow: DKK 3.5 billion for the first nine months. CapEx: 5% of sales for the first nine months. Warning! GuruFocus has detected 4 Warning Signs with CLPBF. Release Date: August 19, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Coloplast AS (CLPBF) reported a 7% organic growth for the third quarter, driven by broad-based growth across its Chronic Care businesses. The company has reorganized its structure into two business units, Chronic Care and Acute Care, to better address market dynamics and customer needs. Coloplast AS (CLPBF) is focusing on innovation, with plans to bring new products to market faster and enhance R&D capabilities. The company has maintained a stable EBIT margin of 27% to 28% before special items, demonstrating effective cost management. Kerecis, a part of the Advanced Wound Care segment, showed strong growth of 26% in the first nine months, indicating robust demand for its products. Negative Points The Advanced Wound Care business fell short of expectations due to product returns in China and lower-than-expected growth for Kerecis. The US Centers for Medicare and Medicaid Services proposed rules that could impact Coloplast AS (CLPBF)'s Chronic Care business, introducing uncertainty about future financial impacts. The company faced a negative impact from foreign exchange rates, which reduced reported revenue by approximately 1%. Coloplast AS (CLPBF) experienced a product recall in China, leading to a significant negative financial impact in the third quarter. The Bladder Health and Surgery segment continued to detract from growth, with uncertainty around the timeline for full recovery. Q & A Highlights Q: Lars, we've seen product recalls and execution issues. What steps are you taking to prevent future recalls? A: Lars Rasmussen, Interim CEO: The recall of urological products was due to a sterilization barrier breach, a common issue in the industry. The situation in China with Biatain foam products is different; it's a technical specification issue unique to China, not a quality problem. We're discussing this with the market and working on substitute products, but it's a slow process. Q: Can you elaborate on the INTIBIA filing and your confidence in regulatory acceptance? A: Anders Lonning-Skovgaard, CFO: We are on track with the INTIBIA launch and expect to get it through the FDA process in the US. We anticipate launching in the first part of the next strategic period. Q: Regarding Kerecis, how was growth in non-physician office settings, and what are the incentives for physicians to use higher-priced products? A: Anders Lonning-Skovgaard, CFO: In Q3, high-priced products reentered the market due to an LCD delay, impacting sales. We expect a bounce back in Q4. The new skin substitute price is being discussed and expected to be implemented in January 2026. Q: On the competitive bidding proposal, can you provide more details on the potential impact on US Chronic Care sales? A: Lars Rasmussen, Interim CEO: It's difficult to estimate the impact, but competitive bidding on specialized products like Ostomy Care seems illogical due to the complexity and variety of SKUs. We estimate around 50% of our US sales are Medicare-related. Q: Can you explain the rationale behind establishing R&D franchises within Chronic Care? A: Lars Rasmussen, Interim CEO: Innovation is crucial, and we aim to bring products to market faster and derive more value from them. This change elevates R&D to the executive level to ensure close collaboration with manufacturing, enhancing both innovation and profitability. For the complete transcript of the earnings call, please refer to the full earnings call transcript.
